Teladoc Health, Inc. (TDOC)

6.57 0.01 (0.15%)

As of 2026-05-22 14:59:45 EST

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

Traded asNYSE: TDOC
ISINUS87918A1051
CIK0001477449
LEI549300I2PVFBC9MFAC61
EIN043705970
SectorMedical care
IndustryServices-Offices & Clinics of Doctors of Medicine
CEOChuck Divita, III
Employees5,000
Fiscal Year End1231
Address155 E 44TH STREET, NEW YORK, NY, 10017
Phone2036352002
Websitehttp://teladochealth.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
TDOCTeladoc Health, Inc.2026-05-22 14:59:456.570.010.15
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
TDOC0001477449Teladoc Health, Inc.US87918A1051549300I2PVFBC9MFAC61043705970NYSE8011Services-Offices & Clinics of Doctors of Medicine1231DE155 E 44TH STREETNEW YORKNY10017UNITED STATESUS2036352002155 E 44TH STREET, NEW YORK, NY, 10017155 E 44TH STREET, NEW YORK, NY, 10017Teladoc, Inc.Medical care2002Chuck Divita, III5,000http://teladochealth.com1,531,762,802180,431,102180,513,087Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.2026-05-21 17:10:30
This is a preview of the latest data. Subscribe to access the full data.
TDOC Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
TDOC Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20251,531,762,802-134,308,902-8.0614178,396,4344,724,4022.7203
20241,666,071,704-2,478,568,464-59.8018173,672,0326,633,0663.971
20234,144,640,168-1,189,394,842-22.2982167,038,9664,421,7742.7191
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Carlos NuenoPresident2025589,55202,000,000564,20195,3733,249,126
Kelly BlissPresident2025516,66702,099,997331,50014,0002,962,164
Charles DivitaChief Executive Officer2025800,00009,699,996584,000119,00011,202,996
Mala MurthyChief Financial Officer2025489,37503,299,998014,0003,803,373
Adam C. VandervoortSecretary, Chief Legal Officer2025495,00002,099,997247,00014,0002,855,997
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20255,600
20245,500
20235,600
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue2,529,977,0002,569,574,0002,602,415,000
Cost Of Revenue771,593,000751,270,000760,031,000
Gross Profit1,758,384,0001,818,304,0001,842,384,000
Research And Development Expenses277,922,000307,274,000348,521,000
General And Administrative Expenses431,891,000435,490,000464,659,000
Operating Expenses2,792,932,0003,590,460,0002,850,968,000
Operating Income-262,955,000-1,020,886,000-248,553,000
Net Income-200,322,000-1,001,245,000-220,368,000
Earnings Per Share Basic-1.14-5.87-1.34
Earnings Per Share Diluted-1.14-5.87-1.34
Weighted Average Shares Outstanding Basic176,221,530170,564,088164,578,219
Weighted Average Shares Outstanding Diluted176,221,530170,564,088164,578,219
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents781,084,0001,298,327,0001,123,675,000
Marketable Securities Current———
Accounts Receivable192,826,000214,146,000217,423,000
Inventories38,203,00038,138,00029,513,000
Non Trade Receivables8,834,0009,809,00012,640,000
Other Assets Current2,071,0002,828,0007,443,000
Total Assets Current1,119,129,0001,663,907,0001,489,048,000
Marketable Securities Non Current———
Property Plant And Equipment26,972,00029,487,00032,032,000
Other Assets Non Current105,803,00081,488,00080,258,000
Total Assets Non Current26,972,00029,487,00032,032,000
Total Assets2,858,300,0003,516,524,0004,392,369,000
Accounts Payable47,967,00033,130,00043,637,000
Deferred Revenue62,305,00079,296,00095,659,000
Short Term Debt———
Other Liabilities Current22,942,00027,427,00033,691,000
Total Liabilities Current404,738,000941,535,000420,616,000
Long Term Debt994,925,000991,418,0001,538,688,000
Other Liabilities Non Current643,000720,0001,080,000
Total Liabilities Non Current1,067,856,0001,083,910,0001,645,680,000
Total Liabilities1,472,594,0002,025,445,0002,066,296,000
Common Stock178,000173,000167,000
Retained Earnings-16,430,222,000-16,229,900,000-15,228,655,000
Accumulated Other Comprehensive Income-34,728,000-38,388,000-36,990,000
Total Shareholders Equity1,385,706,0001,491,079,0002,326,073,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization———
Share Based Compensation Expense80,414,000145,951,000201,550,000
Other Non Cash Income Expense-6,399,000-9,796,000310,000
Change In Accounts Receivable-25,126,000375,00010,252,000
Change In Inventories-399,0009,749,000-24,095,000
Change In Non Trade Receivables———
Change In Other Assets-7,997,0001,257,00023,052,000
Change In Accounts Payable11,454,000-10,365,000-4,185,000
Change In Other Liabilities13,296,000-20,499,00019,180,000
Cash From Operating Activities294,357,000293,680,000350,021,000
Purchases Of Marketable Securities27,875,000——
Sales Of Marketable Securities740,00000
Acquisition Of Property Plant And Equipment8,893,00010,790,00011,464,000
Acquisition Of Business81,904,0001,743,0000
Other Investing Activities-60,0000-1,000
Cash From Investing Activities-266,003,000-124,052,000-156,347,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock3,000,0003,566,0001,481,000
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities0-2,0000
Cash From Financing Activities-551,652,0008,312,00010,854,000
Change In Cash-523,298,000177,940,000204,528,000
Cash At End Of Period781,084,0001,298,327,0001,123,675,000
Income Taxes Paid8,745,0008,946,0007,238,000
Interest Paid15,008,00017,322,00017,422,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-1.14-5.87-1.34
Price To Earnings Ratio-6.1404-1.5486-16.0821
Earnings Growth Rate-80.5792338.0597-98.4161
Price Earnings To Growth Ratio0.0762-0.00460.1634
Book Value Per Share7.86348.74214.1335
Price To Book Ratio0.89021.03981.5247
Ebitda———
Enterprise Value1,447,391,7101,243,518,559.923,961,673,619.45
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.7180.66490.6615
Capital Expenditures———
Free Cash Flow———
Return On Equity-0.1446-0.6715-0.0947
One Year Beta1.3911.47282.2992
Three Year Beta1.62091.94361.9197
Five Year Beta1.73071.01341.0506
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Paulus Kenneth HDirector2026-05-2130,441A30,441
Jacobson CatherineDirector2026-05-2130,441A30,441
Smith Mark DouglasDirector2026-05-2130,441A30,441
Fenwick Sandra LDirector2026-05-2130,441A30,441
SNOW DAVID B JRDirector2026-05-2130,441A30,441
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Donald Sternoff Beyer2020-05-12VA08Sale2020-04-27Joint$1,001 - $15,000
Bradley S. Schneider2018-07-15IL10Purchase2017-06-04Spouse$15,001 - $50,000
Bradley S. Schneider2018-06-10IL10Purchase2018-05-04Spouse$100,001 - $250,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Western Wealth Management, LLC2026-03-318181505.4533
McIlrath & Eck, LLC2026-03-315501015.4455
Twin Lakes Capital Management, LLC2026-03-3116,5903,0445.4501
JANUS HENDERSON GROUP PLC2026-03-311,429,430262,2155.4514
Arkadios Wealth Advisors2026-03-3164,07611,7575.45
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
iSHARES TRUST2026-03-31iShares U.S. Healthcare Providers ETFIHF208,1271,134,292.150.1752
Bridge Builder Trust2026-03-31Bridge Builder Small/Mid Cap Growth FundBBGSX515,2072,807,878.150.0304
Bridge Builder Trust2026-03-31Bridge Builder Small/Mid Cap Value FundBBVSX62,968343,175.60.0038
Federated Hermes Equity Funds2026-03-31Class R6 SharesVSFSX65,986359,623.70.2393
Federated Hermes Equity Funds2026-03-31Class R SharesVSFRX65,986359,623.70.2393
This is a preview of the latest data. Subscribe to access the full data.